These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 15616035

  • 1. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.
    Wang JJ, Zhang SX, Lu K, Chen Y, Mott R, Sato S, Ma JX.
    Diabetes; 2005 Jan; 54(1):243-50. PubMed ID: 15616035
    [Abstract] [Full Text] [Related]

  • 2. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.
    Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor inhibits high glucose induced oxidative stress and fibrosis of cultured human glomerular mesangial cells.
    Mao T, Gao L, Li H, Li J.
    Saudi Med J; 2011 Aug; 32(8):769-77. PubMed ID: 21858384
    [Abstract] [Full Text] [Related]

  • 5. Pigment epithelium-derived factor inhibits high glucose-induced JAK/STAT signalling pathway activation in human glomerular mesangial cells.
    Mao T, Chen H, Hong L, Li J.
    Saudi Med J; 2013 Aug; 34(8):793-800. PubMed ID: 23974449
    [Abstract] [Full Text] [Related]

  • 6. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
    Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, Imaizumi T, Yamakawa R.
    Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
    [Abstract] [Full Text] [Related]

  • 7. Pigment epithelium‑derived factor protects human glomerular mesangial cells from diabetes via NOXO1‑iNOS suppression.
    Gao L, Hu Y, Li J.
    Mol Med Rep; 2017 Nov; 16(5):7855-7863. PubMed ID: 28944893
    [Abstract] [Full Text] [Related]

  • 8. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y, Matsui T, Ishibashi Y, Takeuchi M, Yamagishi S.
    Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
    [Abstract] [Full Text] [Related]

  • 9. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
    Amano S, Yamagishi S, Inagaki Y, Nakamura K, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
    Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX.
    FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
    [Abstract] [Full Text] [Related]

  • 11. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
    Ishibashi Y, Matsui T, Taira J, Higashimoto Y, Yamagishi S.
    Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of pigment epithelium-derived factor within the penile tissues contributes to erectile dysfunction in diabetic rats.
    Qiao H, Zhang Y, Lin W, Wang YF, Furdui CM, Jiang Q, Li X, Long T, Wang Y, Qin DN.
    Clin Sci (Lond); 2018 Oct 31; 132(20):2175-2188. PubMed ID: 30232174
    [Abstract] [Full Text] [Related]

  • 13. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina.
    Lashbrook BL, Steinle JJ.
    Auton Neurosci; 2005 Aug 31; 121(1-2):33-9. PubMed ID: 15961351
    [Abstract] [Full Text] [Related]

  • 14. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX, Wang JJ, Gao G, Parke K, Ma JX.
    J Mol Endocrinol; 2006 Aug 31; 37(1):1-12. PubMed ID: 16901919
    [Abstract] [Full Text] [Related]

  • 15. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 31; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 16. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex.
    Che D, Fang Z, Yan L, Du J, Li F, Xie J, Feng J, Yin P, Qi W, Yang Z, Ma J, Yang X, Gao G, Zhou T.
    Diabetologia; 2020 Sep 31; 63(9):1857-1871. PubMed ID: 32377760
    [Abstract] [Full Text] [Related]

  • 17. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy.
    Wang B, Atherton P, Patel R, Manning G, Donnelly R.
    Microvasc Res; 2010 Jul 31; 80(1):31-6. PubMed ID: 20219495
    [Abstract] [Full Text] [Related]

  • 18. Pigment epithelium derived factor play a positive role in bone mineralization of osteoblasts derived from diabetic patients.
    Song N, Zhong J, Zhang J, Yu J, Li J, Qi J, Yang J, Qiu Y, Su W, Feng Z, Wang H.
    Gene; 2017 Sep 05; 627():563-568. PubMed ID: 28698158
    [Abstract] [Full Text] [Related]

  • 19. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
    Maeda S, Matsui T, Takeuchi M, Yoshida Y, Yamakawa R, Fukami K, Yamagishi S.
    Pharmacol Res; 2011 Mar 05; 63(3):241-8. PubMed ID: 21115116
    [Abstract] [Full Text] [Related]

  • 20. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.
    Ophthalmic Res; 2007 Mar 05; 39(2):92-7. PubMed ID: 17284935
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.